Immunome Inc. — Director's Dealing 2020

Nov 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunome Inc. (IMNM)
CIK: 0001472012
Period of Report: 2020-11-03

Reporting Person: Stoneman Sandra G. (Chief Legal Officer & Gen Coun)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-03	Employee Stock Option (Right to Buy)	$11.38	A	148837	Acquired	2030-11-03	Common Stock (148837)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option shall vest on October 26, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter.